Article
- The EMBO Journal (2006) 25, 4763 - 4772
- doi:10.1038/sj.emboj.7601365
Published online: 5 October 2006
Subject Category:
Receptor specific downregulation of cytokine signaling by autophosphorylation in the FERM domain of Jak2
Megumi Funakoshi-Tago1, Stephane Pelletier1, Tadashi Matsuda2, Evan Parganas1 and James N Ihle1
- Department of Biochemistry, St Jude Children's Research Hospital, Memphis, TN, USA
- Department of Immunology, Hokkaido University, Sapporo, Japan
Correspondence to:
James N Ihle, Department of Biochemistry, St Jude Children's Research Hospital, Memphis, TN 38120, USA. Tel.: +1 901 495 3422; Fax: +1 901 525 8025; E-mail: james.ihle@stjude.org
Received 20 July 2005; Accepted 30 August 2006
Abstract
The tyrosine kinase, Janus kinase-2 (Jak2), plays a pivotal role in signal transduction through a variety of cytokine receptors, including the receptor for erythropoietin (Epo). Although the physiological relevance of Jak2 has been definitively established, less is known about its regulation. In studies assessing the roles of sites of tyrosine phosphorylation, we identified Y119 in the FERM (band 4.1, Ezrin, radixin and moesin) domain as a phosphorylation site. In these studies, we demonstrate that the phosphorylation of Y119 in response to Epo downregulates Jak2 kinase activity. Using a phosphorylation mimic mutation (Y119E), downregulation is shown to involve dissociation of Jak2 from the receptor complex. Conversely, a Y119F mutant is more stably associated with the receptor complex. Thus, in cytokine responses, ligand binding induces activation of receptor associated Jak2, autophosphorylation of Y119 in the FERM domain and the subsequent dissociation of the activated Jak2 from the receptor and degradation. This regulation occurs with the receptors for Epo, thrombopoietin and growth hormone but not with the receptor for interferon-
.
Keywords:
- autophosphorylation,
- cytokine receptor,
- FERM domain,
- Jak kinases,
- Jak2



